| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.1M | +1.9% |
| R&D Expense | $2.2M | +1.6% |
| SG&A Expense | $6.5M | -23.9% |
| Operating Income | -$7.7M | +18.2% |
| Pre-tax Income | -$8.3M | +21.6% |
| Income Tax | $14K | +76.5% |
| Net Income | -$8.3M | +33.6% |
| EPS (Basic) | -$2.67 | +76.5% |
| EPS (Diluted) | -$2.67 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.0M | +117.0% |
| Accounts Receivable | $938K | +181.9% |
| Current Assets | $7.5M | +60.2% |
| Total Assets | $11.2M | +30.7% |
| Current Liabilities | $952K | -77.1% |
| Long-term Debt | $1.1M | +18.5% |
| Total Liabilities | $2.4M | -56.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.7M | +36.3% |
| Capital Expenditures | $46K | +214.1% |
| Investing Cash Flow | -$929K | -2.5% |
| Financing Cash Flow | $9.9M | +4.2% |
| Free Cash Flow | -$5.7M | +35.8% |
| +76.5% |
| Stockholders' Equity |
| $8.7M |
| +188.3% |